CARDIAC ALLOGRAFT VASCULOPATHY
Clinical trials for CARDIAC ALLOGRAFT VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC ALLOGRAFT VASCULOPATHY trials appear
Sign up with your email to follow new studies for CARDIAC ALLOGRAFT VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart transplant patients may get new shield against artery disease
Disease control Recruiting nowThis study tests if starting antiplatelet medication (blood thinners) soon after a heart transplant can prevent a common complication called cardiac allograft vasculopathy (CAV), which narrows the heart's arteries. About 135 adult heart transplant recipients will receive either a…
Matched conditions: CARDIAC ALLOGRAFT VASCULOPATHY
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
Heart transplant patients may soon skip invasive artery checks
Knowledge-focused Recruiting nowThis study tests if a noninvasive PET scan is as good as the standard invasive angiogram for monitoring heart transplant patients for a common complication called cardiac allograft vasculopathy (CAV), which narrows heart arteries. About 576 adults who had a heart transplant 2-10 …
Matched conditions: CARDIAC ALLOGRAFT VASCULOPATHY
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated May 17, 2026 08:48 UTC